NCT00932256View on ClinicalTrials.gov

Clinical Trial of STAHIST in Seasonal Allergic Rhinitis Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

October 31, 2009

Study Completion Date

December 31, 2010

Conditions
Rhinitis, Allergic, Seasonal
Interventions
DRUG

STAHIST NDC #58407-536-01

Oral tablet containing Pseudoephedrine hydrochloride 90mg, chlorpheniramine maleate 8mg, atropine sulfate .24mg, one tablet BID.

Trial Locations (1)

40215

Family Allergy and Asthma Research Institute, Louisville

Sponsors
All Listed Sponsors
lead

Magna Pharmaceuticals, Inc.

INDUSTRY